Should total serum IgA be obtained when screening for celiac disease together with the standard IgA-based serologic panel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Total Serum IgA Should Always Be Measured When Screening for Celiac Disease

Total serum IgA must be obtained alongside the standard IgA-based celiac panel (tissue transglutaminase-IgA) to avoid missing celiac disease in patients with IgA deficiency. 1

Why This Is Critical

IgA deficiency occurs in approximately 2-3% of celiac disease patients (10-15 times higher than the general population), and these patients will have falsely negative IgA-based antibody tests despite having active celiac disease 1. Missing this diagnosis has significant implications for morbidity—untreated celiac disease leads to malabsorption, osteoporosis, increased malignancy risk, and other serious complications.

The Algorithmic Approach

Initial Screening Panel Should Include:

  • Tissue transglutaminase-IgA (tTG-IgA) - primary screening test
  • Total serum IgA - to identify IgA deficiency
  • Consider endomysial antibody-IgA (EmA-IgA) for confirmation in certain cases 1

If Total IgA Is Low or Deficient:

  • Order IgG-based tests: tTG-IgG, deamidated gliadin peptide-IgG (DGP-IgG), or EmA-IgG 1, 2
  • These patients should be classified as having "celiac disease with selective IgA deficiency" rather than seronegative celiac disease if IgG antibodies are positive 2

Important Caveat:

IgG isotype testing for tTG is NOT specific in the absence of IgA deficiency 1—meaning you should not routinely order IgG tests unless IgA deficiency is documented.

Evidence Quality and Strength

The 2019 AGA Clinical Practice Update 1 and the 2021 AGA Update on Seronegative Enteropathies 2 both explicitly recommend measuring total IgA levels as part of the diagnostic workup. The 2023 ACG Guidelines 3 reinforce this approach. This represents the highest quality guideline evidence available.

Common Pitfalls to Avoid

  1. Ordering only tTG-IgA without total IgA: Studies show this occurs in 20% of real-world practice 4, leading to missed diagnoses

  2. Assuming normal tTG-IgA rules out celiac disease: In IgA-deficient patients, tTG-IgA will be falsely negative regardless of disease presence

  3. Ordering IgG tests routinely: Only order IgG-based tests when IgA deficiency is confirmed—they lack specificity otherwise 1

Alternative Approaches (Less Reliable)

Some research suggests that very low optical density readings on tTG-IgA ELISA assays may correlate with IgA deficiency 5, 6, potentially reducing the need for universal IgA testing. However, this requires careful assay-specific validation and is not recommended as standard practice. The safest approach remains universal total IgA measurement 1, 2.

Clinical Reality

Despite clear guidelines, total IgA is inconsistently ordered—particularly by endocrinologists (only 49% compliance in one study) 7. Among patients who do have IgA measured during celiac screening, IgA deficiency prevalence is approximately 5% 4, confirming this is not a rare occurrence and justifies universal screening.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.